Universitätsklinikum Köln

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis. (2021) Tietz AK, Angstwurm K, Baumgartner T, Doppler K, Eisenhut K, Elisak M, Franke A, et al. Journal article Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study. (2021) Nickenig G, Friedrichs KP, Baldus S, Arnold M, Seidler T, Hakmi S, Linke A, et al. Journal article Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy (2021) Haas M, Mirocha J, Amann KU, Bajema IM, Barisoni L, Becker JU, Jennette JC, et al. Journal article Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer (2021) Schneeweiss A, Michel LL, Möbus V, Tesch H, Klare P, Hahnen E, Denkert C, et al. Journal article Erratum: AGO Recommendations for the Surgical Therapy of the Axilla after Neoadjuvant Chemotherapy: 2021 Update (Geburtshilfe Frauenheilkd (2021) 81:10 (1112-1120) DOI: 10.1055/a-1499-8431) (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Paluchowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Erratum Analgesia after tonsillectomy with controlled intravenous morphine — overdue or exaggerated? (2021) Gostian M, Loeser J, Bentley T, Wolber P, Schwarz D, Balk M, Gostian AO Journal article Bone Fractures in Children and Young Adults With Type 1 Diabetes: Age Distribution, Fracture Location, and the Role of Glycemic Control (2021) Eckert AJ, Semler O, Schnabel D, Köstner K, Wurm D, Bechtold-Dalla Pozza S, Schaaf K, et al. Journal article Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial (2021) Llop-Guevara A, Loibl S, Villacampa G, Vladimirova V, Schneeweiss A, Karn T, Zahm DM, et al. Journal article Phase III post-neoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA (2021) Marme F, Hanusch C, Furlanetto J, Denkert C, Link T, Untch M, Blohmer JU, et al. Conference contribution Erratum zu Mitteilungen der Deutschen Gesellschaft für Pathologie (Der Pathologe, (2021), 42, 3, (352-353), 10.1007/s00292-021-00931-y) (2021) Joehrens K, Baretton G, Schildhaus HU, Agaimy A, Scheel A, Schwammborn K, Laenger F, et al. Journal article, Erratum